Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - STOCK-BASED COMPENSATION
Stock-based Compensation NBIX - Neurocrine Biosciences, Inc.
196 M
LAST VALUE
6.27%
2 YEAR CAGR
21.04%
5 YEAR CAGR
34.12%
10 YEAR CAGR